Publication Number
WO/2026/174520
Publication Date
27.08.2026
International Application No.
PCT/CN2025/078473
International Filing Date
21.02.2025
Applicants
-
SIRONAX SWITZERLAND GMBH
[GB]/[CH]
Inventors
-
LIU, Qian
-
ZHANG, Ke
-
YANG, Shenglian
-
TONG, Yingtao
-
ZHANG, Yonghong
-
ZHANG, Nan
-
ZHAO, Rongqing
-
GUAN, Chenbing
Agents
-
CHINA PATENT AGENT (H.K.) LTD.
Priority Data
Publication Language
English (en)
Filing Language
English (en)
Designated States
AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CV, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IQ, IR, IS, IT, JM, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, MG, MK, MN, MU, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UY, UZ, VC, VN, WS, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, CV, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SC, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Title
(EN) NOVEL NANOBODIES SPECIFIC FOR CD98 HEAVY CHAIN AND METHODS OF USES THEREOF
(FR) NANOANTICORPS NOUVEAUX SPÉCIFIQUES DE LA CHAÎNE LOURDE CD98 ET MÉTHODES D'UTILISATION DE CEUX-CI
Abstract
(EN) Disclosed herein are novel nanobodies and antigen-binding domains that specifically bind to human CD98 heavy chain (CD98hc) and their use in, for example, transport across the blood brain barrier (BBB). Among others, bispecific antibodies targeting CD98hc and Aβ and their uses in, for example, treating neurological diseases are also provided.
(FR) Sont divulgués ici de nouveaux nanoanticorps et domaines de liaison à l'antigène qui se lient spécifiquement à la chaîne lourde CD98 humaine (CD98hc) et leur utilisation dans, par exemple, le transport à travers la barrière hémato-encéphalique (BHE). Sont également fournis, entre autres, des anticorps bispécifiques ciblant CD98hc et Aβ et leurs utilisations dans, par exemple, le traitement de maladies neurologiques.
Latest bibliographic data on file with the International Bureau
The publication of an international application under the Patent Cooperation Treaty in PATENTSCOPE (which constitutes an element of the Gazette) does not imply the expression of any opinion whatsoever on the part of the International Bureau of WIPO concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.